Zomedica Statistics
Total Valuation
Zomedica has a market cap or net worth of 84.18 million. The enterprise value is 41.87 million.
| Market Cap | 84.18M |
| Enterprise Value | 41.87M |
Important Dates
The next confirmed earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zomedica has 979.95 million shares outstanding.
| Current Share Class | 979.95M |
| Shares Outstanding | 979.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.96% |
| Owned by Institutions (%) | 0.07% |
| Float | 949.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.28 |
| PB Ratio | 0.78 |
| P/TBV Ratio | 1.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.43, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.43 |
| Quick Ratio | 5.57 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.13 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -16.29% and return on invested capital (ROIC) is -10.95%.
| Return on Equity (ROE) | -16.29% |
| Return on Assets (ROA) | -10.19% |
| Return on Invested Capital (ROIC) | -10.95% |
| Return on Capital Employed (ROCE) | -19.01% |
| Weighted Average Cost of Capital (WACC) | 11.56% |
| Revenue Per Employee | 261,539 |
| Profits Per Employee | -134,397 |
| Employee Count | 141 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 2.17 |
Taxes
| Income Tax | -168,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +117.95% in the last 52 weeks. The beta is 1.38, so Zomedica's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +117.95% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 47.69 |
| Average Volume (20 Days) | 742,055 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.19 |
Income Statement
In the last 12 months, Zomedica had revenue of 36.88 million and -18.95 million in losses. Loss per share was -0.02.
| Revenue | 36.88M |
| Gross Profit | 24.13M |
| Operating Income | -20.75M |
| Pretax Income | -19.12M |
| Net Income | -18.95M |
| EBITDA | -13.20M |
| EBIT | -20.75M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 44.13 million in cash and 1.83 million in debt, with a net cash position of 42.30 million or 0.04 per share.
| Cash & Cash Equivalents | 44.13M |
| Total Debt | 1.83M |
| Net Cash | 42.30M |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | 107.28M |
| Book Value Per Share | 0.11 |
| Working Capital | 48.89M |
Cash Flow
In the last 12 months, operating cash flow was -13.37 million and capital expenditures -302,000, giving a free cash flow of -13.67 million.
| Operating Cash Flow | -13.37M |
| Capital Expenditures | -302,000 |
| Depreciation & Amortization | 7.55M |
| Net Borrowing | n/a |
| Free Cash Flow | -13.67M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 65.44%, with operating and profit margins of -56.28% and -51.39%.
| Gross Margin | 65.44% |
| Operating Margin | -56.28% |
| Pretax Margin | -51.84% |
| Profit Margin | -51.39% |
| EBITDA Margin | -35.80% |
| EBIT Margin | -56.28% |
| FCF Margin | n/a |
Dividends & Yields
Zomedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -22.51% |
| FCF Yield | -16.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zomedica has an Altman Z-Score of 1.62 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.62 |
| Piotroski F-Score | 2 |